Table 1. Patient demographics.

Characteristic	Total (%)
Number of patients receiving 131I-MIBG	48 (100)
Female	27 (56.3)
Male	21 (43.8)
Mean age at time of diagnosis	57.6 (s.d. 10.9)
Mean age at time of first 131I-MIBG	61.7 (s.d. 10.0)
Presenting symptoms
Diarrhoea	29 (60.4)
Flushing	28 (58.3)
Abdominal pain	20 (41.7)
Weight loss	15 (31.3)
Fatigue/tiredness	8 (16.7)
Bloating/distension	7 (14.5)
Breathlessness	6 (12.5)
Vomiting	5 (10.4)
Haemoptysis	3 (6.3)
Sweats	3 (6.3)
Loss of appetite	2 (4.2)
Site of primary tumour
Small bowel	17 (33.3)
Lung	6 (12.5)
Pancreas	5 (10.4)
Caecum	3 (6.3)
Ascending colon	2 (4.2)
Liver	1 (2.1)
Stomach	1 (2.1)
Appendix	1 (2.1)
Unknown	12 (25.0)
Presence of metastases	48 (100)
Liver	44 (91.7)
Bone	4 (8.3)
Lymph node	13 (27.1)
Previous surgery	29 (60.4)
Small bowel resection	13 (27.1)
Right hemicolectomy	7 (14.6)
Other relevant resection	7 (14.6)
Shunt/bypass	7 (14.6)
Liver resection	6 (12.5)
Other treatments
Somatostatin analogues	37 (77.1)
Chemotherapy	6 (12.5)
Interferon-α	2 (4.2)
Radiofrequency ablation	1 (2.1)
Hepatic chemoembolisation	7 (14.6)